In vivo positionable filtration devices and methods related thereto

Patent metadata

Field	Value
Publication number	US-12036348-B2
Application number	US-202217860574-A
Country	US
Kind code	B2
Filing date	Jul 8, 2022
Priority date	Dec 21, 2012
Publication date	Jul 16, 2024
Grant date	Jul 16, 2024

Abstract

In vivo positionable filtration devices are provided that filter one or more therapeutic agents in blood flowing in a blood vessel. The filtration devices include an elongated member and a filtering component coupled to the elongated member. The elongated member and the filtering component are dimensioned for positioning within the blood vessel. Further, the filtering component includes a filtration material to filter the one or more therapeutic agents from the blood. Methods of in vivo filtration of the one or more therapeutic agents are also provided. The methods include positioning a filtration device of the filtration devices in the blood vessel, and administering a therapeutic agent of the one or more therapeutic agents upstream from a target tissue site to direct flow of the therapeutic agent to the target tissue site and then to the filtration device. The filtration device is positioned downstream from the target tissue site.

First claim

We claim:

1. A method for filtering one or more chemotherapeutic agents in blood flowing in a blood vessel within a patient, the method comprising:
introducing a distal end of an elongate member carrying a filtering component into the blood vessel downstream from a target tissue site;
deploying the filtering component within the blood vessel, the filtering component comprising a porous membrane including a proximal end and a distal end and configured such that the blood flowing through the blood vessel passes through an interior of the filtering component; and
administering a chemotherapeutic agent of the one or more chemotherapeutic agents upstream from the target tissue site to direct flow of the chemotherapeutic agent to the target tissue site and then to the filtering component,
wherein the filtering component comprises a filtration material disposed within the porous membrane configured to bind or adsorb the chemotherapeutic agent as the blood flows through the interior of the filtering component,
wherein the filtration material comprises a plurality of beads comprising a resin that binds or adsorbs the chemotherapeutic agent.

2. The method of claim 1 , wherein the porous membrane is shaped to increase and then decrease in cross-sectional area from the distal end of the porous membrane to the proximal end.

3. The method of claim 1 , wherein the porous membrane is expandable to occupy a cross sectional area of the vein within which the porous membrane is deployed.

4. The method of claim 1 , wherein the target tissue site is within the patient's kidney or liver.

5. The method of claim 1 , wherein the blood vessel is a renal or hepatic vein.

6. The method of claim 1 , wherein the plurality of beads comprises an ion exchange resin.

7. The method of claim 1 , wherein the plurality of beads comprises a strong acid cation polymer resin.

8. The method of claim 1 , wherein the filtration material is coated with heparin, polymethyl-methacrylate, or chitosan.

9. A method for filtering one or more chemotherapeutic agents in blood flowing in a blood vessel within a patient, the method comprising:
introducing a distal end of an elongate member carrying a filtering component into the blood vessel downstream from a target tissue site;
expanding the filtering component within the blood vessel, the filtering component comprising a porous membrane including a proximal end and a distal end, the porous membrane expanding within the blood vessel such that the blood flowing through the blood vessel passes into the distal end through an interior of the filtering component and out the proximal end; and
administering a chemotherapeutic agent of the one or more chemotherapeutic agents upstream from the target tissue site to direct flow of the chemotherapeutic agent to the target tissue site and then to the filtering component,
wherein the filtering component comprises a filtration material disposed within the porous membrane configured to bind the chemotherapeutic agent as the blood flows through the interior of the filtering component,
wherein the filtration material comprises a plurality of beads comprising a resin that binds or adsorbs the chemotherapeutic agent.

10. The method of claim 9 , wherein the porous membrane is shaped to increase and then decrease in cross-sectional area from the distal end of the porous membrane to the proximal end.

11. The method of claim 9 , wherein the chemotherapeutic agent is doxorubicin.

12. The method of claim 9 , wherein the target tissue site is within the patient's kidney or liver.

13. The method of claim 9 , wherein the blood vessel is a renal or hepatic vein.

14. The method of claim 9 , wherein the plurality of beads comprises an ion exchange resin.

15. The method of claim 9 , wherein the plurality of beads comprises a strong acid cation polymer resin.

16. The method of claim 9 , wherein the filtration material is coated with heparin, polymethyl-methacrylate, or chitosan.

17. The method of claim 9 , further comprising removing the filtering component from the blood vessel while the elongate member remains within the blood vessel.

18. A method for filtering one or more chemotherapeutic agents in blood flowing in a blood vessel within a patient, the method comprising:
introducing a distal end of an elongate member carrying a filtering component into the blood vessel downstream from a target tissue site;
deploying the filtering component within the blood vessel, the filtering component comprising a porous membrane including a proximal end and a distal end and configured such that the blood flowing through the blood vessel passes through an interior of the filtering component; and
administering a chemotherapeutic agent of the one or more chemotherapeutic agents upstream from the target tissue site to direct flow of the chemotherapeutic agent to the target tissue site and then to the filtering component,
wherein the filtering component comprises a filtration material disposed within the porous membrane configured to bind or adsorb the chemotherapeutic agent as the blood flows through the interior of the filtering component,
wherein the filtration material comprises a plurality of beads comprising a resin that traps or captures the chemotherapeutic agent.

19. The method of claim 18 , wherein the porous membrane is shaped to increase and then decrease in cross-sectional area from the distal end of the porous membrane to the proximal end of the porous membrane.

20. The method of claim 18 , wherein the porous membrane is expandable to occupy a cross sectional area of the vein within which the porous membrane is deployed.

21. The method of claim 18 , wherein the deployment of the filtering component comprises expanding the filtering component within the blood vessel.

Assignees

• Univ California

Inventors

• Hetts Steven W
• Patel Anand S
• Wilson Mark W

Classifications

• A61F2/0108

  Both ends closed, i.e. legs gathered at both ends · CPC title

• A61F2/0105

  Open ended, i.e. legs gathered only at one side · CPC title

• A61F2/011

  Instruments for their placement or removal · CPC title

• A61M1/3679

  by absorption (A61M1/3675 takes precedence) · CPC title

• A61M25/0029

  characterized by features relating to least one lumen located at the middle part of the catheter, e.g. slots, flaps, valves, cuffs, apertures, notches, grooves or rapid exchange ports (catheter shaft surface irregularities A61M2025/006) · CPC title